A Contract Research Organization with an academic advantage

We partner with investigators and pharmaceutical, biotechnology, nutritional, and medical device industries to execute your Phase I to IV clinical studies including hybrid and decentralized clinical trials.

Innovation is at the core of our business

Who we are

The Montreal Health Innovations Coordinating Center (MHICC) is a full service academic clinical research organization (CRO), providing services to the academic community and to the pharmaceutical, biotechnology and medical device industries, in the fields of cardiology, neurology, oncology, gastroenterology, endocrinology, pharmacogenomics and more. The MHICC’s flexible, dynamic and fully integrated "a la carte" range of services can meet the needs of Phase I to IV clinical projects, from protocol conception to delivery of clinical study report.

Armed with a new digital platform and tools, the MHICC further distinguishes itself by its ability to conduct hybrid or virtual/decentralized clinical trials (limited or no visits to clinical sites and/or hospitals).

Learn more

Why choose the MHICC

Established since 2001, with specific expertise in precision medicine clinical studies, innovative clinical trials, advanced analytics, and expert insight, the MHICC brings undeniable specialized capabilities to customers across the healthcare ecosystem.
Decentralized Trial
The virtual/decentralized approach advocates the use of new technologies (digital platform and tools) in an integrated, patient-centered approach, allowing patients to participate in clinical trials from the comfort of their homes.
Learn more
Therapeutic Areas
With more than 20 years of global experience founded on medical science, MHICC’s major therapeutic areas of focus include cardiology, neurology, oncology, gastroenterology, endocrinology and many more.
The MHICC is a leading academic clinical research organization that has successfully conducted more than 75 clinical trials and 7 registries since its inception. Along with Medical Experts’ easy access from the Montreal Heart Institute, the MHICC has a network of research collaborators at more than 4,500 clinical sites in 35 countries.
The Pharmacogenomics Centre is dedicated to the advance of knowledge and promoting discoveries in precision medicine. The Centre provides opportunities to expand and enhance existing research programs through the inclusion of genetic, proteomic information and statistical analysis at all phases of drug development using variety of platforms that operate under strict quality assurance criteria and under good laboratory practice (GLP)
Learn more
The Biobank aims to explore the relationship between genes and cardiovascular disease. Since the project began, the Biobank recruited more than 21,000 participants whose blood samples made it possible to collect DNA, plasma and red blood cells. Medical, genealogical, dietary, psychosocial and lifestyle data are also gathered. What makes the Biobank unique is that this personal information is updated every four years and participants are tracked throughout their lives.
Learn more
CDISC Delivrables
Looking for a CRO with CDISC experience? Let MHICC prepare your data submission package so you can submit your data with confidence. MHICC is a CDISC Platinium member and implements Trial Design in CDASH, SDTM, ADaM and Define-XML.
Patient Partnership
Patient partnerships link the study personnel knowledgeable in trial conduct with the patients living with the disease to make better decisions regarding the study. For example, the patients may contribute towards the study by sharing their perspective and personal experience for consideration (e.g. virtual vs. in-person visits; online vs. paper data collection; selection of certain technology, questionnaires, or assessments; feedback on sampling instructions, websites, etc.).